Public consultation on the guideline ”Process of information retrieval for systematic reviews and health technology assessments on clinical effectiveness” in August/September 2019

The methodological guideline ”Process of information retrieval for systematic reviews and health technology assessments on clinical effectiveness” is currently under revision by IQWiG, NIPHNO and AETSA. It will be made available for public consultation as of beginning of August for the duration of approximately 2 months.

OTCA15 – Final Assessment and input from external experts and manufacturers are now available

We are pleased to announce that the final assessment for OTCA15 “Irreversible electroporation in liver and pancreatic cancer”, together with the input from external experts and manufacturers, are now available for access. Irreversible electroporation (IRE) is a nonthermal ablative method based on the application of short high-voltage and low-frequency electric fields to destroy tissue. The purpose of […]

EUnetHTA Magazine – Summer 2019 – Now available

We are pleased to roll out the next issue of EUnetHTA Magazine. As we are now experimenting with a web-based format, we hope to provide a more interactive experience for readers, whether that’s on desktop, tablet, or mobile device. In this issue we have healthcare thoughts from Finland, updates from MD and an interview with […]

”Patient Input in Relative Effectiveness Assessments” is now available.

EUnetHTA is pleased to announced that the document on “Patient Input in Relative Effectiveness Assessments” is now available. The document describes the process regarding direct patient input in REAs within JA3. The document is primarily intended for those who design and conduct EUnetHTA REAs, although it may be informative for a wider audience of patients, […]

HTAi 2019 Annual Meeting – Cologne!

​This year’s HTAi Annual Meeting will take place from 15 to 19 June in Cologne, Germany. The meeting brings together HTA experts from across the world for five days of discussions, panels, presentations and more. This year’s theme “HTA beyond 2020: Ready for the New Decade” focusses on what the future development of HTA worldwide looks like as a number of prominent strategies and […]

PTJA04 – “Sotagliflozin indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy” is now available

This is the assessment of the relative effectiveness of  ‘Sotagliflozin indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy.’ Below is the documentation provided by […]

This website uses cookies to ensure you get the best experience on our website. By using the website you agree to our Privacy Policy and our Terms of Use.